MANKIND PHARMA, the fourth biggest player in the domestic pharmaceutical market rang the stock exchanges bell in early May this year, since then the company’s stock has been the north star rising over 23 per cent in less than four months from its listing price. The company posted handsome results for FY23 and for quarter one of FY24 with revenues rising by 12.4 per cent to Rs 8,749 crore and by 18 per cent to Rs 2,579 crore respectively. The company’s 97 per cent of revenues are generated within India.
Speaking exclusively to BW Businessworld, Rajeev Juneja, Vice Chairman and Managing Director, Mankind Pharma says the company is not focused on stock market but the attention is always on the company’s long-term growth which will keep its stock healthy. “We should be the most admired and respected company. Our ambition is to become an institution which is loved by its consumers and the rest of the metrics such as the stock market and valuation will always be a by-product,” Juneja states.
Growth In Pharma Market
Juneja believes that the Indian pharmaceutical market will be growing by 7-9 per cent in FY24. He says this growth will be mainly due to the changing epidemiology of disease patterns with rising chronic diseases. This, he states, is being caused by sedentary lifestyles, stressful times, rising air pollution and the postCovid effects on the body which are still being probed. “The population of India is also increasing, hence consumption of medicines will keep on rising,” the MD highlights.
This story is from the 21 October 2023 edition of BW Businessworld.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the 21 October 2023 edition of BW Businessworld.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Recreating The Maruti Moment In EVs
SAJJAN JINDAL on the joint venture with MG Motor, electric mobility, charging infrastructure and more
A Conduit Between Spiritual and Tech Realms
In November 2023, Vama secured a Seed Plus round led by Wavemaker Partners, bringing its total funding to USS 2.8 million
The Power Of Numerology
Renowned numerologist C CHAUDHRY strives to take numerology at par with other occult sciences
"We Are Dominating India's Astrology Market With 80-85 per cent Share"
Recording a consistent uptick on the growth graph and riding high on the spiritual tech wave in India, the founders of Astrotalk, PUNEET GUPTA and ANMOL JAIN are excited to capitalise on rising consumer demand with sights set on an IPO launch. Edited excerpts from a conversation with BW Businessworld’s Resham Suhail
Nothing is Better than Something
I RECENTLY CAME ACROSs an interesting titbit about the Apple iPad. Something that illustrates a dilemma we face all the time.
Advancing Urban Water Security in India
IN THE HEART of Bengaluru, once celebrated as the City of Lakes, an unfolding drama of scarcity paints a stark contrast against its historic abundance.
UNEQUAL NOTES.HARMONISING FISCAL SYMPHONY
THE INDIAN ECONOMY pulsates with diverse regional rhythms, creating a complex symphony of growth.
BUDGET 2024: We Need a System Thinking Approach to Rescript the India Story
While the nation is caught up in election fever, let us focus on the 2024 interim Union Budget presented by the Union Finance Minister, Nirmala Sitharaman. This could be a game-changing budget to rescript India’s growth story.
CARVING A NICHE IN THE PET CARE BOOM
With a remarkable turnout of over 20,000 attendees in its early stages, Pet Fed has swiftly become India's leading pet festival.
ZIGLY'S DRIVE FROM DISARRAY TO ORGANISED PET CARE
During a conversation with BW Business world, PANKAJ PODDAR, Group CEO of Zigly's parent company, Cosmo First, delves into the industry's increasing allure to international investors, shedding light on the startup's contribution to this trend
